Discovery of hit molecules targeting allosteric site of hepatitis C virus NS5B polymerase

References

• Beaulieu, P. L., Bös, M., Bousquet, Y., DeRoy, P., Fazal, G., Gauthier, J., … Kukolj, G. (2004). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: Discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency. Bioorganic & Medicinal Chemistry Letters, 14(4), 967–971. doi:10.1016/j.bmcl.2003.12.032
   PubMed Web of Science ®Google Scholar
• Beaulieu, P. L., Bös, M., Bousquet, Y., Fazal, G., Gauthier, J., Gillard, J., … Kukolj, G. (2004). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: Discovery and preliminary SAR of benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters, 14(1), 119–124. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14684311 doi:10.1016/j.bmcl.2003.10.023
   PubMed Web of Science ®Google Scholar
• Beaulieu, P. L., Bousquet, Y., Gauthier, J., Gillard, J., Marquis, M., McKercher, G., … Kukolj, G. (2004). Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: Inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells. Journal of Medicinal Chemistry, 47(27), 6884–6892. doi:10.1021/jm040134d
   PubMed Web of Science ®Google Scholar
• Beaulieu, P. L., Gillard, J., Bykowski, D., Brochu, C., Dansereau, N., Duceppe, J.-S., … Kukolj, G. (2006). Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: From benzimidazole to indole scaffolds. Bioorganic & Medicinal Chemistry Letters, 16(19), 4987–4993. doi:10.1016/j.bmcl.2006.07.074
   PubMed Web of Science ®Google Scholar
• Beaulieu, P. L., & Tsantrizos, Y. S. (2004). Inhibitors of the HCV NS5B polymerase: New hope for the treatment of hepatitis C infections. Current Opinion in Investigational Drugs (London, England: 2000), 5(8), 838–850. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15600240
   PubMedGoogle Scholar
• Biswal, B. K., Wang, M., Cherney, M. M., Chan, L., Yannopoulos, C. G., Bilimoria, D., … James, M. N. G. (2006). Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. Journal of Molecular Biology, 361(1), 33–45. doi:10.1016/j.jmb.2006.05.074
   PubMed Web of Science ®Google Scholar
• Di Marco, S., Volpari, C., Tomei, L., Altamura, S., Harper, S., Narjes, F., … Carfí, A. (2005). Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. Journal of Biological Chemistry, 280(33), 29765–29770. doi:10.1074/jbc.M505423200
   PubMed Web of Science ®Google Scholar
• Duan, J., Dixon, S. L., Lowrie, J. F., & Sherman, W. (2010). Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods. Journal of Molecular Graphics & Modelling, 29(2), 157–170. doi:10.1016/j.jmgm.2010.05.008
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. doi:10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Habermann, J., Capitò, E., Ferreira, M. D. R. R., Koch, U., & Narjes, F. (2009). Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase. Bioorganic & Medicinal Chemistry Letters, 19(3), 633–638. doi:10.1016/j.bmcl.2008.12.039
   PubMed Web of Science ®Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. doi:10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Harper, S., Avolio, S., Pacini, B., Di Filippo, M., Altamura, S., Tomei, L., … Narjes, F. (2005). Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. Journal of Medicinal Chemistry, 48(14), 4547–4557. doi:10.1021/jm050056+
   PubMed Web of Science ®Google Scholar
• Harper, S., Pacini, B., Avolio, S., Di Filippo, M., Migliaccio, G., Laufer, R., … Narjes, F. (2005). Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. Journal of Medicinal Chemistry, 48(5), 1314–1317. doi:10.1021/jm049122i
   PubMed Web of Science ®Google Scholar
• Hepatitis, C. (1996). Seroprevalence of hepatitis C virus (HCV) in a population sample. Relevé Épidémiologique Hebdomadaire/Section D’hygiène Du Secrétariat de La Société Des Nations = Weekly Epidemiological Record/Health Section of the Secretariat of the League of Nations, 71(46), 346–349. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8961810
   PubMedGoogle Scholar
• Hirashima, S., Suzuki, T., Ishida, T., Noji, S., Yata, S., Ando, I., … Hashimoto, H. (2006). Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: Structure–activity relationship studies and identification of a potent and highly selective inhibitor JTK-109. Journal of Medicinal Chemistry, 49(15), 4721–4736. doi:10.1021/jm060269e
   PubMed Web of Science ®Google Scholar
• Ikegashira, K., Oka, T., Hirashima, S., Noji, S., Yamanaka, H., Hara, Y., … Hashimoto, H. (2006). Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors. Journal of Medicinal Chemistry, 49(24), 6950–6953. [Mismatch] doi:10.1021/jm0610245
   PubMed Web of Science ®Google Scholar
• Ivanov, A. V., Korovina, A. N., Tunitskaya, V. L., Kostyuk, D. A., Rechinsky, V. O., Kukhanova, M. K., & Kochetkov, S. N. (2006). Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteins. Protein Expression and Purification, 48(1), 14–23. doi:10.1016/j.pep.2006.02.011
   PubMed Web of Science ®Google Scholar
• Kaushik-Basu, N., Bopda-Waffo, A., Talele, T. T., Basu, A., Costa, P. R. R., da Silva, A. J. M., … Noel, F. (2008). Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucleic Acids Research, 36(5), 1482–1496. doi:10.1093/nar/gkm1178
   PubMed Web of Science ®Google Scholar
• Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery, 3(11), 935–949. doi:10.1038/nrd1549
   PubMed Web of Science ®Google Scholar
• Kristensen, T. G., Nielsen, J., & Pedersen, C. N. S. (2010). A tree-based method for the rapid screening of chemical fingerprints. Algorithms for Molecular Biology: AMB, 5, 9. doi:10.1186/1748-7188-5-9
   PubMed Web of Science ®Google Scholar
• Lengauer, T., & Rarey, M. (1996). Computational methods for biomolecular docking. Current Opinion in Structural Biology, 6(3), 402–406. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8804827 doi:10.1016/S0959-440X(96)80061-3
   PubMed Web of Science ®Google Scholar
• Lesburg, C. A., Radfar, R., & Weber, P. C. (2000). Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase. Current Opinion in Investigational Drugs (London, England: 2000), 1(3), 289–296. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11249710
   PubMedGoogle Scholar
• Love, R. A., Parge, H. E., Yu, X., Hickey, M. J., Diehl, W., Gao, J., … Fuhrman, S. A. (2003). Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. Journal of Virology, 77(13), 7575–7581. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi/artid=164784&tool=pmcentrez&rendertype=abstract doi:10.1128/JVI.77.13.7575-7581.2003
   PubMed Web of Science ®Google Scholar
• Malancona, S., Donghi, M., Ferrara, M., Martin Hernando, J. I., Pompei, M., Pesci, S., … Summa, V. (2010). Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: Structure-based design and synthesis of new templates. Bioorganic & Medicinal Chemistry, 18(8), 2836–2848. doi:10.1016/j.bmc.2010.03.024
   PubMed Web of Science ®Google Scholar
• Martin Hernando, J. I., Ontoria, J. M., Malancona, S., Attenni, B., Fiore, F., Bonelli, F., … Narjes, F. (2009). Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase. ChemMedChem, 4(10), 1695–1713. doi:10.1002/cmdc.200900184
   PubMed Web of Science ®Google Scholar
• McKercher, G., Beaulieu, P. L., Lamarre, D., LaPlante, S., Lefebvre, S., Pellerin, C., … Kukolj, G. (2004). Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate. Nucleic Acids Research, 32(2), 422–431. doi:10.1093/nar/gkh160
   PubMed Web of Science ®Google Scholar
• Morris, G. M., & Lim-Wilby, M. (2008). Molecular docking. Methods in Molecular Biology (Clifton, N.J.), 443, 365–382. doi:10.1007/978-1-59745-177-2_19
   PubMedGoogle Scholar
• Narjes, F., Crescenzi, B., Ferrara, M., Habermann, JRG., Colarusso, Stefania, del Rosario Rico Ferreira, Maria, … Rowley, Michael. (2011). Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase. Journal of Medicinal Chemistry, 54(1), 289–301. doi:10.1021/jm1013105
   PubMed Web of Science ®Google Scholar
• Nyanguile, O., Pauwels, F., Van den Broeck, W., Boutton, C. W., Quirynen, L., Ivens, T., … Raboisson, P. (2008). 1,5-Benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors. Antimicrobial Agents and Chemotherapy, 52(12), 4420–4431. doi:10.1128/AAC.00669-08
   PubMed Web of Science ®Google Scholar
• Ontoria, J. M., Martìn Hernando, J. I., Malancona, S., Attenni, B., Stansfield, I., Conte, I., … Narjes, F. (2006). Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters, 16(15), 4026–4030. doi:10.1016/j.bmcl.2006.05.012
   PubMed Web of Science ®Google Scholar
• Ontoria, Jesus M., Rydberg, Edwin H., Di Marco, Stefania, Tomei, Licia, Attenni, Barbara, Malancona, Savina, … Carfì, Andrea. (2009). Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors. Journal of Medicinal Chemistry, 52(16), 5217–5227. doi:10.1021/jm900517t
   PubMed Web of Science ®Google Scholar
• Rong, F., Chow, S., Yan, S., Larson, G., Hong, Z., & Wu, J. (2007). Structure–activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters, 17(6), 1663–1666. doi:10.1016/j.bmcl.2006.12.103
   PubMed Web of Science ®Google Scholar
• Stansfield, I., Pompei, M., Conte, I., Ercolani, C., Migliaccio, G., Jairaj, M., … Narjes, F. (2007). Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters, 17(18), 5143–5149. doi:10.1016/j.bmcl.2007.06.093
   PubMed Web of Science ®Google Scholar
• Wasley, A., & Alter, M. J. (2000). Epidemiology of hepatitis C: Geographic differences and temporal trends. Seminars in Liver Disease, 20(1), 1–16. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10895428
   PubMed Web of Science ®Google Scholar
• Wolber, G., & Langer, T. (2005). LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45(1), 160–169. doi:10.1021/ci049885e
   PubMed Web of Science ®Google Scholar
• Yan, S., Appleby, T., Larson, G., Wu, J. Z., Hamatake, R., Hong, Z., & Yao, N. (2006). Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors. Bioorganic & Medicinal Chemistry Letters, 16(22), 5888–5891. doi:10.1016/j.bmcl.2006.08.056
   PubMed Web of Science ®Google Scholar